L94.2 Calcinosis cutis

Name of the Condition

• Calcinosis cutis

Summary

Calcinosis cutis is a condition characterized by the deposition of calcium salts in the skin and subcutaneous tissues. This results in firm, often painful nodules or plaques that may ulcerate or discharge chalky material. The condition can occur in various clinical settings, including as a complication of connective tissue diseases, metabolic disorders, or local tissue injury. The extent and severity depend on the underlying cause and the distribution of calcium deposits.

Causes

The causes of calcinosis cutis are diverse and include dystrophic, metastatic, idiopathic, and iatrogenic mechanisms. Dystrophic calcification occurs in damaged or inflamed tissues without systemic calcium abnormalities, often linked to connective tissue disorders like systemic sclerosis or dermatomyositis. Metastatic calcification results from elevated serum calcium or phosphate levels, seen in conditions such as hyperparathyroidism or chronic kidney disease. Idiopathic calcinosis may arise without a clear underlying cause, while iatrogenic cases relate to medical procedures or treatments, such as extravasation of calcium-containing solutions.

Risk Factors

• Connective tissue diseases: Systemic sclerosis, dermatomyositis, and lupus increase risk.
• Metabolic disorders: Chronic kidney disease, hyperparathyroidism, or vitamin D toxicity.
• Local tissue damage: Trauma, infection, or inflammation in the affected area.
• Iatrogenic factors: Intravenous calcium administration or extravasation injuries.
• Genetic predisposition: Rare familial forms may occur.

Symptoms

• Firm, painless or tender subcutaneous nodules or plaques.
• Skin discoloration, often white or yellowish, overlying deposits.
• Ulceration or discharge of chalky material from lesions.
• Restricted movement if deposits affect joints or tendons.
• Recurrent inflammation or infection of affected areas.

Diagnosis

Diagnosis is based on clinical presentation and confirmed by histopathological examination of tissue samples, which reveals calcium deposits. Imaging studies, such as X-rays or ultrasound, may identify calcifications. Laboratory tests assess serum calcium, phosphate, and renal function to rule out metabolic causes. A thorough history, including medication use and underlying conditions, is essential to determine the etiology.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. For dystrophic calcinosis, therapies may include anti-inflammatory agents, bisphosphonates, or surgical excision of severe lesions. Metastatic cases require correction of electrolyte imbalances. Local measures, such as wound care for ulcerated lesions, and pain management are often necessary. In some instances, dietary modifications or discontinuation of offending medications may be indicated.

Prognosis and Follow-Up

Prognosis varies with the underlying cause and extent of calcification. Dystrophic forms may stabilize or progress slowly, while metastatic cases improve with correction of metabolic abnormalities. Regular follow-up is important to monitor for complications, such as infection or functional impairment. Imaging or clinical assessments may be repeated to track lesion progression or response to treatment.

Complications

• Chronic pain or discomfort from lesions.
• Skin ulceration and secondary infection.
• Functional impairment due to joint or tendon involvement.
• Cosmetic concerns affecting quality of life.
• Recurrence after surgical removal.

Lifestyle & Prevention

• Manage underlying conditions, such as autoimmune or metabolic disorders, to reduce risk.
• Protect skin from trauma or injury to prevent localized deposits.
• Maintain regular medical check-ups to monitor for early signs.
• Follow prescribed treatments for associated diseases to minimize calcification risk.

When to Seek Professional Help

Seek medical attention if you notice new, firm skin nodules, especially with pain, ulceration, or discharge. Prompt evaluation is important if lesions affect mobility or appear infected. Individuals with known connective tissue or metabolic disorders should report changes to their healthcare provider to address potential complications.

Tips for Medical Coders

When coding for calcinosis cutis (L94.2), ensure documentation specifies the underlying cause or clinical context, such as dystrophic, metastatic, or idiopathic. Note the location and extent of lesions, as well as any associated conditions, to support accurate coding. Verify that the diagnosis aligns with clinical findings and exclude other calcification-related codes unless multiple etiologies are present.